Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Melpida by Elpida Therapeutics for Paraplegia: Likelihood of Approval
Melpida is under clinical development by Elpida Therapeutics and currently in Phase II for Paraplegia. According to GlobalData, Phase II...